Benjamin Solomon
MBBS, PhD
Medical Oncologist and Professor
👥Biography 个人简介
Benjamin Solomon led the ALINA trial which established two years of adjuvant alectinib as new standard for resected stage IB-IIIA ALK-positive NSCLC, showing dramatic disease-free survival benefit versus platinum chemotherapy. His work extends ALK-targeted strategies from metastatic to curative-intent settings. He has been central to global ALK drug development from crizotinib onward.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Benjamin Solomon 的研究动态
Follow Benjamin Solomon's research updates
留下邮箱，当我们发布与 Benjamin Solomon（Peter MacCallum Cancer Centre）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment